Luqman Elisa V 4

What Happened

• Luqman Elisa V, Chief Legal Officer of Nutex Health (NUTX), had 2,084 restricted stock units (RSUs) convert into common stock on March 10, 2026 (conversion reported as code M). To satisfy tax withholding, 784 of those shares were sold (code F) at $86.22 each for proceeds of $67,598. The filing also reports a new grant of 1,525 RSUs on March 11, 2026 that vest in three equal installments on March 1, 2027, 2028 and 2029.

Key Details

• Transaction dates and amounts:
  • Mar 10, 2026: 2,084 RSUs converted to 2,084 shares (acquired at $0.00 per share, code M).
  • Mar 10, 2026: 784 shares sold/used for tax withholding at $86.22 each (disposed, code F) — proceeds $67,598.
  • Mar 11, 2026: 1,525 RSUs granted (vesting in three equal installments 2027–2029).
• Shares owned after transaction: reporting person beneficially owns 2,370 shares (2,360 direct + 10 indirect via spouse), per the filing.
• Footnotes: RSUs convert one-for-one to common stock; 784 of the 2,084 vested shares were sold to cover taxes.
• Filing timeliness: Report filed Mar 11, 2026 for Mar 10 transactions — appears timely (filed the next business day).

Context

• This was a standard RSU vesting event with a sell-to-cover for taxes, not an open-market investment decision. Such sell-to-cover transactions are routine and primarily for tax obligations rather than a directional bet on the stock. The new RSU grant vests over three years, so any future benefit depends on continued service and company performance.